|Bid||210.81 x 1000|
|Ask||215.28 x 1200|
|Day's Range||208.13 - 213.68|
|52 Week Range||187.16 - 372.12|
|Beta (5Y Monthly)||0.42|
|PE Ratio (TTM)||21.86|
|Earnings Date||Jul 20, 2022 - Jul 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||238.74|
Armany is a rising junior at Northeastern University majoring in electrical and computer engineering who developed a passion for science during his time as a Biogen Community Lab student and as a R...
CAMBRIDGE, Mass. & NEW YORK, June 22, 2022--Biogen (NASDAQ:BIIB) and Happify Health (www.HappifyHealth.com), the Intelligent Healing Company™, today announced a collaboration to provide a digital solution for patient education and engagement, powered by artificial intelligence (AI), to support people living with multiple sclerosis (MS). Through this collaboration, Biogen and Happify Health will help people with MS manage their care journey, improve their wellbeing, learn about treatment options,
Ionis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is evaluating eplontersen in hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).